Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.
Opinion Statement: Bronchial carcinoids are uncommon tumors accounting for 20 to 30% of all neuroendocrine tumors and about 1-2% of all cancers of pulmonary origin. Bronchial carcinoids are well-differentiated neuroendocrine tumors and have a favorable survival outcome when compared with other subty...
| Publicado en: | Current Treatment Options in Oncology Vol. 21; no. 11; pp. 1 - 20 |
|---|---|
| Autores principales: | , , , |
| Formato: | review Journal Article |
| Publicado: |
Springer Nature
Nov2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |